Trial Details
RECRUITINGBasic Information
| Clinical ID | c280 |
|---|---|
| Identifier | NCT06850727 |
| Trial Title | Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|UC - Ulcerative Colitis |
| Interventions | DRUG: OD-07656|DRUG: Vedolizumab |
Participant Information
| Sponsor | Odyssey Therapeutics |
|---|---|
| City | Birtinya |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-06-02 |
|---|---|
| Primary Completion Date | 2026-04 |
| Completion Date | 2026-11 |